Globus Medical Inc

NYSE:GMEDHealthcareNASDAQ:NQUSMGSTOXX:EDD24BP

$78.55+3.83%LiveIn session · ≈ AED 288.46 · Market cap $10.55B · Next earnings Thu 5 Nov

GMED · Income statement · TradingHolo

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	0.8	1.0	1.0	1.6	2.5	2.9	3.1	+7.0%
Cost of revenue	0.2	0.2	0.3	0.5	1.0	1.0	1.0	+3.3%
Gross profit	0.6	0.7	0.8	1.0	1.5	2.0	2.1	+4.4%
Research & development	0.1	0.1	0.1	0.1	0.2	0.2	0.1	−20.5%
Selling, general & administrative	0.4	0.4	0.4	0.6	1.0	1.3	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Operating expenses	0.5	0.5	0.5	0.9	1.3	1.5	—	—
Operating income	0.1	0.2	0.2	0.1	0.2	0.5	0.7	+36.0%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other income / expense	0.0	0.0	0.0	0.0	(0.0)	0.1	—	—
Pre-tax income	0.1	0.2	0.2	0.2	0.1	0.6	0.7	+8.2%
Income tax	0.0	0.0	0.1	0.0	0.0	0.1	0.1	+73.2%
Net income	0.1	0.1	0.2	0.1	0.1	0.5	0.5	−0.5%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	1.04	1.48	1.89	1.09	0.76	3.98	3.97	−0.4%
EPS, diluted (per share)	1.01	1.44	1.85	1.07	0.75	3.92	3.91	−0.3%
EBITDA	0.2	0.3	0.3	0.3	0.5	0.7	0.9	+26.9%
Depreciation & amortization	0.1	0.1	0.1	0.1	0.3	0.1	0.3	+133.3%
Weighted average shares (shares)	98,580,000	100,734,000	100,469,000	113,087,000	135,726,000	135,150,754	—	—
Weighted average diluted shares (shares)	100,971,000	103,623,000	102,643,000	114,630,000	137,863,000	137,219,388	—	—
Gross margin	72.4%	75.0%	74.2%	65.1%	58.9%	67.4%	65.8%	−1.6 pts
Operating margin	14.1%	17.9%	22.3%	8.5%	6.6%	16.3%	20.8%	+4.4 pts
Net margin	13.0%	15.6%	18.6%	7.8%	4.1%	18.3%	17.0%	−1.3 pts

USD billionsUpdated Thu 6 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.